CoChat

True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours

Rehfeld, Jens F., Broedbaek, Kasper, Goetze, Jens P., Knigge, Ulrich, Hilsted, Linda M. · 2020 · Scandinavian Journal of Gastroenterology

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Objective: The incidence of enteropancreatic neuroendocrine tumours (NET) is increasing. Chromogranin A (CgA) in plasma is a marker in patients suspected of NET tumours. CgA, however, is a precursor protein subjected to cellular processing that challenges quantitation and hence the use of CgA in diagnostics.Materials and methods: CgA concentrations in plasma sampled from 130 well-characterized patients with small intestinal NETs and from 30 healthy subjects were measured with eight commercial CgA kits, an in-house radioimmunoassay (RIA) and a processing-independent assay (PIA). For the evaluation of diagnostic accuracy, we performed regression analyses and plotted receiver-operating characteristic curves (ROC). The specificity was further assessed by size chromatography.Results: Five commercial assays (Thermo-Fisher, DRG Diagnostics, Eurodiagnostica (RIA and ELISA), and Phoenix), displayed a diagnostic accuracy with area under the curve (AUC) values >0.90, whereas three immunoassays (Yanaihara, CisBio RIA, and CisBio ELISA) discriminated poorly between disease stages (AUC: 0.60–0.78). Compared with the in-house assays, however, even the most accurate commercial immunoassay still missed patients with metastatic disease. Chromatography showed non-uniform patterns of large and small CgA fragments in plasma.Conclusion: Available commercial immunoassays measure CgA in plasma with gross variability. Three commercial CgA immunoassays discriminate so poorly between health and disease that they should not be used. The highest diagnostic accuracy was obtained with processing-independent measurement of total CgA concentrations in plasma.

Overview

Integrity signals

Registry

Crossref · 10.1080/00365521.2020.1759141

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Helle KB, 2010, Results Probl Cell Differ, 50, 21

Cited by

See all 13

Metadata

Authors
Rehfeld, J. F., Broedbaek, K., Goetze, J. P., Knigge, U., & Hilsted, L. M.
Affiliations
University of Copenhagen (DK)
Corresponding author
Hilsted, Linda M.
Venue
Scandinavian Journal of Gastroenterology
Published
2020-04-30
Volume
55
Issue
5
Pages
565-573
ISSN
  • 0036-5521 (ISSN-L)
  • 1502-7708
OpenAlex
W3022561214
Cited by
13
References
37
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 5 · 2020: 2
FWCI
1.62
Type
journal article
Language
en
Open access
closed
Locations
  • Scandinavian Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
chromogranin A, small bowel neuroendocrine tumors, plasma biomarkers, metastasis detection, tumor markers
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Humans, Immunoassay, Intestinal Neoplasms, Male, Middle Aged, Pancreatic Neoplasms, Plasma, Regression Analysis, ROC Curve, Stomach Neoplasms, Biomarkers, Tumor, Neuroendocrine Tumors, Chromogranin A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours. https://app.cochat.ai/papers/10.1080/00365521.2020.1759141
The paper
Rehfeld, J. F., Broedbaek, K., Goetze, J. P., Knigge, U., & Hilsted, L. M. (2020). True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours. Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/00365521.2020.1759141

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.